Cargando…

Countercurrents: DCIS or Cancer? Why All the Confusion?

At present, women with ductal carcinoma in situ are counseled that they have a pre-malignant condition which carries the possibility of progression to a fully malignant breast cancer. However, in most cases, the treatment of DCIS resembles that of a small invasive breast cancer and this is a source...

Descripción completa

Detalles Bibliográficos
Autores principales: Narod, Steven A., Sopik, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316925/
https://www.ncbi.nlm.nih.gov/pubmed/35877252
http://dx.doi.org/10.3390/curroncol29070392
_version_ 1784754932614692864
author Narod, Steven A.
Sopik, Victoria
author_facet Narod, Steven A.
Sopik, Victoria
author_sort Narod, Steven A.
collection PubMed
description At present, women with ductal carcinoma in situ are counseled that they have a pre-malignant condition which carries the possibility of progression to a fully malignant breast cancer. However, in most cases, the treatment of DCIS resembles that of a small invasive breast cancer and this is a source of confusion to many. In order to properly evaluate the benefit of radiotherapy, mastectomy and contralateral mastectomy, it is necessary to consider the risks of ipsilateral invasive cancer and of contralateral breast cancer in women with DCIS and with small invasive breast cancer. Several registry-based studies indicate that the risks of ipsilateral and contralateral cancer are similar in the two conditions and therefore a similar approach to treatment is rational.
format Online
Article
Text
id pubmed-9316925
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93169252022-07-27 Countercurrents: DCIS or Cancer? Why All the Confusion? Narod, Steven A. Sopik, Victoria Curr Oncol Commentary At present, women with ductal carcinoma in situ are counseled that they have a pre-malignant condition which carries the possibility of progression to a fully malignant breast cancer. However, in most cases, the treatment of DCIS resembles that of a small invasive breast cancer and this is a source of confusion to many. In order to properly evaluate the benefit of radiotherapy, mastectomy and contralateral mastectomy, it is necessary to consider the risks of ipsilateral invasive cancer and of contralateral breast cancer in women with DCIS and with small invasive breast cancer. Several registry-based studies indicate that the risks of ipsilateral and contralateral cancer are similar in the two conditions and therefore a similar approach to treatment is rational. MDPI 2022-07-13 /pmc/articles/PMC9316925/ /pubmed/35877252 http://dx.doi.org/10.3390/curroncol29070392 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Narod, Steven A.
Sopik, Victoria
Countercurrents: DCIS or Cancer? Why All the Confusion?
title Countercurrents: DCIS or Cancer? Why All the Confusion?
title_full Countercurrents: DCIS or Cancer? Why All the Confusion?
title_fullStr Countercurrents: DCIS or Cancer? Why All the Confusion?
title_full_unstemmed Countercurrents: DCIS or Cancer? Why All the Confusion?
title_short Countercurrents: DCIS or Cancer? Why All the Confusion?
title_sort countercurrents: dcis or cancer? why all the confusion?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316925/
https://www.ncbi.nlm.nih.gov/pubmed/35877252
http://dx.doi.org/10.3390/curroncol29070392
work_keys_str_mv AT narodstevena countercurrentsdcisorcancerwhyalltheconfusion
AT sopikvictoria countercurrentsdcisorcancerwhyalltheconfusion